suggestions for contributors. Metabolism is a huge field and is intimately involved in many diseases, although for this issue we have focused on diabetes, obesity, and energy metabolism.
production. The contribution from Adrienne Mottis et al. examines the maintenance of mitochondrial proteostasis and of cell and organism health. It reviews the protein quality control network and the role of the relatively newly discovered mitochondrial unfolded protein response and considers how fine-tuning of these processes could be used in treatment of metabolic diseases.
Metabolic homeostasis requires signaling between many organs, tissues, and cells. Mary LaPierre et al. report on how the hypothalamus responds to hormones and nutrients to regulate hepatic glucose output and glucose homeostasis. This includes the exciting recent work from the Lam laboratory on glucagon signaling in the hypothalamus. The review from James Cantley returns to the theme of adipose tissue in detailing the influence of adipose tissue-secreted 'adipokines' in insulin secretion. Plasma sulfur amino acids in humans are correlated with body composition and Amany Elshorbagy reviews these relationships and how knockout mouse models have been useful in beginning to understand how sulfur amino acid metabolism is linked to body composition. Finally, within this theme of metabolic regulation, Abram Katz and Häken Westerblad review the effects of exercise on skeletal muscle function and adaption. Two reviews deal with modeling of disease in the laboratory mouse. Jesse Riordan and Joe Nadeau describe non-alcoholic fatty liver disease (NAFLD) modeling in the mouse and how well-defined model systems can be used to understand the transition in some individuals from this relatively mild state to the more serious pathologies of nonalcoholic steatohepatitis (NASH) and further to liver cancer. Michelle Goldsworthy and Paul Potter discuss the use of the mouse in modeling aging-related diseases, describing the Harwell aging mutagenesis screens.
In the last section, we have four articles on metabolic phenotyping in the mouse. The mouse remains an important model in metabolism and is being used to understand the function of individual genes, for example, in the study of candidate genes identified from human genome wide association studies (GWAS) and in more systematic programs to link phenotypes to genes by the international mouse phenotyping consortium (IMPC). Metabolic phenotyping requires the application of techniques on mice that are well defined in terms of genetics and environment and that use standardized operating procedures-if the results are to be robust and reproducible. The rigorous application of the ARRIVE guidelines (Kilkenny et al. (2010) ), for example, should help in the generation of accurate preclinical data that can be used to further our understanding of metabolic disease and develop new therapeutic opportunities. Robust animal studies are essential (for further discussion see, for example, Perrin (2014) ) and these reviews address some of these issues. The reviews by Jan Rozman et al. and HuiYoung Lee et al. cover many of the standardized metabolic phenotyping procedures used in the mouse. Curtis Hughey et al. discuss sophisticated approaches to assessing glucose homeostasis in the conscious mouse and explore some of the issues around study design, test selection, and interpretation of data. Finally, Steven Ciciotte et al. describe techniques for imaging the whole mouse pancreas, which are important in understanding the role of the islet in diabetes progression.
I hope that you enjoy the reviews that we have collected for this special issue of Mammalian Genome and that they provide a sense of the potential for a greater understanding of metabolism that can be obtained through a proper consideration of the genetics and physiology of mammalian organisms.
